Cargando…
Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments
Depressive symptoms are highly prevalent in patients with cardiac diseases. Co-morbid Depression in cardiac patients causes a significant reduction in health-related quality of life for the patients and inflicts an economic burden on the society. Two types of mechanisms that may explain the link bet...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460711/ https://www.ncbi.nlm.nih.gov/pubmed/31775601 http://dx.doi.org/10.2174/1573403X15666191127104520 |
_version_ | 1783576665191874560 |
---|---|
author | Varghese, Treesa P. Kumar, Anand V. Varghese, Nila M. Chand, Sharad |
author_facet | Varghese, Treesa P. Kumar, Anand V. Varghese, Nila M. Chand, Sharad |
author_sort | Varghese, Treesa P. |
collection | PubMed |
description | Depressive symptoms are highly prevalent in patients with cardiac diseases. Co-morbid Depression in cardiac patients causes a significant reduction in health-related quality of life for the patients and inflicts an economic burden on the society. Two types of mechanisms that may explain the link between depression and cardiac diseases are the psychosocial and physiopathological mechanisms. Physiopathological mechanisms are direct biological mechanisms, which include hyperactivity of non-adrenergic and Hypothalamic Pituitary Adrenal Axis (HPA), abnormal platelet activation, endothelial dysfunction, and inflammatory process. Psychosocial factors include behavioral or lifestyle factors like smoking alcoholism and physical inactivity. Pharmacologic and therapeutic interventions are effective at reducing symptoms of depression in patients with cardiac disorders. Among pharmacological treatment, SSRIs seems to be effective for the reduction of depressive symptoms among patients with cardiac disorders because of their good efficacy and minimal cardiovascular side effects. Mechanisms of action of SSRI’s in depressive patients with cardiac disorders are associated with their ability to reduce inflammation, platelet, and endothelial dysfunction. This review focuses on the potential pathophysiological and psychosocial links between cardiac diseases and depression, the treatment options, and the importance of routine screening of depressive symptoms in cardiac settings. |
format | Online Article Text |
id | pubmed-7460711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-74607112021-05-01 Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments Varghese, Treesa P. Kumar, Anand V. Varghese, Nila M. Chand, Sharad Curr Cardiol Rev Article Depressive symptoms are highly prevalent in patients with cardiac diseases. Co-morbid Depression in cardiac patients causes a significant reduction in health-related quality of life for the patients and inflicts an economic burden on the society. Two types of mechanisms that may explain the link between depression and cardiac diseases are the psychosocial and physiopathological mechanisms. Physiopathological mechanisms are direct biological mechanisms, which include hyperactivity of non-adrenergic and Hypothalamic Pituitary Adrenal Axis (HPA), abnormal platelet activation, endothelial dysfunction, and inflammatory process. Psychosocial factors include behavioral or lifestyle factors like smoking alcoholism and physical inactivity. Pharmacologic and therapeutic interventions are effective at reducing symptoms of depression in patients with cardiac disorders. Among pharmacological treatment, SSRIs seems to be effective for the reduction of depressive symptoms among patients with cardiac disorders because of their good efficacy and minimal cardiovascular side effects. Mechanisms of action of SSRI’s in depressive patients with cardiac disorders are associated with their ability to reduce inflammation, platelet, and endothelial dysfunction. This review focuses on the potential pathophysiological and psychosocial links between cardiac diseases and depression, the treatment options, and the importance of routine screening of depressive symptoms in cardiac settings. Bentham Science Publishers 2020-05 2020-05 /pmc/articles/PMC7460711/ /pubmed/31775601 http://dx.doi.org/10.2174/1573403X15666191127104520 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Varghese, Treesa P. Kumar, Anand V. Varghese, Nila M. Chand, Sharad Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments |
title | Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments |
title_full | Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments |
title_fullStr | Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments |
title_full_unstemmed | Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments |
title_short | Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments |
title_sort | depression related pathophysiologies relevant in heart disease: insights into the mechanism based on pharmacological treatments |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460711/ https://www.ncbi.nlm.nih.gov/pubmed/31775601 http://dx.doi.org/10.2174/1573403X15666191127104520 |
work_keys_str_mv | AT varghesetreesap depressionrelatedpathophysiologiesrelevantinheartdiseaseinsightsintothemechanismbasedonpharmacologicaltreatments AT kumaranandv depressionrelatedpathophysiologiesrelevantinheartdiseaseinsightsintothemechanismbasedonpharmacologicaltreatments AT varghesenilam depressionrelatedpathophysiologiesrelevantinheartdiseaseinsightsintothemechanismbasedonpharmacologicaltreatments AT chandsharad depressionrelatedpathophysiologiesrelevantinheartdiseaseinsightsintothemechanismbasedonpharmacologicaltreatments |